Brainstorm Cell Therapeutics Inc (BCLI)
US$ 1.2-14.89%
Price Chart
Key Statistics
Market Cap
$ 9.69M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
440.47K
52W High
$ 6.60
52W Low
$ 0.72
Dividend Yield
0.00%
Beta
0.21
Technicals
50-Day MA
1.1096
200-Day MA
1.8213
52 Week High
6.5985
52 Week Low
0.7233
About BCLI
Brainstorm Cell Therapeutics Inc. a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases.
Employees
29
Headquarters
New York, NY
CEO
Mr. Chaim Lebovits
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg